Novartis AG | S-8 POS: S-8 POS
Feb 16 05:20
Novartis AG | 6-K: Annual Report 2023 and Novartis in Society - Integrated Report 2023
Jan 31 20:46
Novartis AG | 6-K: Novartis Scemblix® Shows Superior Major Molecular Response (Mmr) Rates Vs. Standard-of-Care Tkis in Phase Iii Trial for Newly Diagnosed Patients with Chronic Myeloid Leukemia
Jan 8 13:00
Novartis AG | 6-K: Novartis Investigational Iptacopan Phase Iii Study Demonstrates Clinically Meaningful and Statistically Significant Proteinuria Reduction in Patients with C3 Glomerulopathy (C3g)
Dec 11, 2023 19:05
Novartis AG | 6-K: Novartis Receives Fda Approval for Fabhalta® (Iptacopan)
Dec 6, 2023 09:19
Novartis AG | 6-K: Novartis Upgrades Mid-Term Sales Growth Guidance, Showcases Its Differentiated Innovative Medicines Strategy and Robust Pipeline at R&d Day
Nov 28, 2023 19:10
Novartis AG | 6-K: Report of Foreign Private Issuer
Oct 30, 2023 18:05
Novartis AG | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Oct 4, 2023 18:57
Novartis AG | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Oct 2, 2023 18:05
Novartis AG | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Aug 9, 2023 18:05
Novartis AG | DFAN14A: Definitive additional proxy soliciting materials filed by non-management
Jul 11, 2023 04:08
Novartis AG | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Jul 10, 2023 18:06
Novartis AG | DFAN14A: Definitive additional proxy soliciting materials filed by non-management
Jun 12, 2023 21:41
Novartis AG | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Jun 12, 2023 21:26
Novartis AG | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Mar 27, 2023 20:14
Novartis AG | S-8 POS: S-8 POS
Mar 25, 2023 05:00
Novartis AG | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Feb 1, 2023 20:55
Novartis AG | S-8 POS: S-8 POS
Jan 11, 2023 05:30
Novartis AG | F-6 POS: Post-effective amendment to a F-6EF registration
Dec 17, 2022 04:42
Novartis AG | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Dec 5, 2022 22:27
No Data
No Data